Constantin Schwab

7PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Contaminant hydrologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance.

Viktoria Schütz, Maresa Rothermel, Adam Kaczorowski

|Sep 05, 2025
Interdisciplinary evidence-based tumor board simulation training in surgical medical education.

Nora Corinna Altmayer, Elias Khajeh, Johanna Fellhofer-Hofer

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Apr 13, 2024
PD-L1 as a Urine Biomarker in Renal Cell Carcinoma-A Case Series and Proof-of-Concept Study.

Philipp Reimold, Georgi Tosev, Adam Kaczorowski

|May 05, 2023
Lethality of SARS-CoV-2 infection-a comparative autopsy study focusing on COVID-19 development and virus variants.

Constantin Schwab, Uta Merle, Peter Schirmacher

Pageof 2